- 10x Genomics, Inc. has performed outstandingly well since the COVID-19 induced lows of March, more than doubling in this time.
- Further, the price has held up in volatile times, showing a slow and steady path up with no significant declines.
- However, I recently trimmed my position slightly in anticipation of a decline that has been occurring in the broader market.
- Was I right in this decision, or will the long-term growth potential prevail and continue to support the stock?
For further details see:
10x Genomics: Overvaluation Leads To A Short-Term Hold/Trim Ranking